The International Congress on Advanced Treatments & Technologies in Multiple Sclerosis (ATTMS2018)

The International Congress on Advanced Treatments & Technologies in Multiple Sclerosis (ATTMS2018) is organized by Bioevents and will be held from Dec 13 - 14, 2018 at Park Plaza Victoria London, London, England, United Kingdom.

Target audience:
• Medical Professionals
• R&D Personnel
• CEOs
• Regulatory Affairs Specialists 
• CROs
• CRAs
• Research Facility Managers
• Pharmaceutical Company Representatives
• Start-Up Companies

Conference Description:
ATTMS2018 aims to be a forum for discussion of advanced technologies for the diagnosis and treatment of Multiple sclerosis.

The Congress will welcome medical professionals, MS specialists, treatment experts, CRO’s, industry leaders and other experts to the majestic city of London.

The congress will focus on the following key areas:
• MRI techniques for the diagnosis of MS and the monitoring of its activity
• Advanced visual function techniques for monitoring of MS activity
• Immune and other biomarkers for MS diagnosis and monitoring of its activity
• Novel and future immunotherapies in MS
• Monoclonal antibodies in MS treatment
• Stem cell therapies in MS
• Vaccinations techniques for MS treatment